Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1684/ejd.2024.4807 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment of Refractory Grover's Disease With Dupilumab: A Case Study.
Cureus
July 2025
Dermatology, Northeast Regional Medical Center, Kirksville, USA.
Grover's disease (GD) is a pruritic skin condition characterized by erythematous, scaly papules on the trunk, often resolving spontaneously but sometimes becoming persistent and difficult to manage. In this case study, we discuss a 73-year-old male with treatment-resistant GD who experienced significant improvement with dupilumab injections. Within two weeks, the patient reported noticeable improvement in pruritus and rash, with complete resolution achieved after five months of continued treatment and no notable adverse effects.
View Article and Find Full Text PDFTransient and unique lesion of acantholytic dyskeratosis of the axilla.
JAAD Case Rep
March 2025
Division of Dermatology, Department of Medicine, University of Sherbrooke, Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Estrie-Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke, Quebec, Canada.
Transient acantholytic dermatosis induced by nivolumab, successfully treated with dupilumab.
Eur J Dermatol
December 2024
Section of Dermatology, Dipartimento di Scienze della Salute (DISSAL), Università degli Studi di Genova, Genoa, Italy, Dermatology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Grover's disease in oncologic patients: clinicopathologic features and systematic review.
Int J Dermatol
March 2025
Unit of Dermatology, IRCCS Ospedale San Raffaele, Milano, Italy.
Grover's Disease Association with Cutaneous Keratinocyte Cancers: More than a Coincidence?
Int J Mol Sci
September 2024
Pathophysiology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Article Synopsis
- * There is a noted but poorly defined connection between GD and cutaneous keratinocyte carcinomas, specifically non-melanoma skin cancers (NMSCs), with very few studies highlighting this relationship between 1983 and 2024.
- * GD has been misdiagnosed as various NMSCs, and understanding this connection could provide insights into its underlying mechanisms, possibly reclassifying GD as a unique syndrome.